

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.27401318 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27401318 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.01114478 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01114478 |
| 5 | actin-myosin filament sliding (GO:0033275) | 6.85398674 |
| 6 | muscle filament sliding (GO:0030049) | 6.85398674 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.46170418 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01153541 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.76455012 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.75037515 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.75037515 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.75037515 |
| 13 | actin-mediated cell contraction (GO:0070252) | 5.73872286 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.73213294 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.69111848 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.64785306 |
| 17 | NADH metabolic process (GO:0006734) | 5.62775085 |
| 18 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.60834241 |
| 19 | skeletal muscle contraction (GO:0003009) | 5.52647162 |
| 20 | urea metabolic process (GO:0019627) | 5.47193477 |
| 21 | urea cycle (GO:0000050) | 5.47193477 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.46772854 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.42053587 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31803136 |
| 25 | protein carboxylation (GO:0018214) | 5.31803136 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30350311 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29456380 |
| 28 | creatine metabolic process (GO:0006600) | 5.28708522 |
| 29 | cysteine metabolic process (GO:0006534) | 5.28197521 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.28134734 |
| 31 | regulation of skeletal muscle contraction (GO:0014819) | 5.23428664 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 5.21550157 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.20186200 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 5.02664908 |
| 35 | regulation of complement activation (GO:0030449) | 4.96995700 |
| 36 | bile acid metabolic process (GO:0008206) | 4.81804785 |
| 37 | lysine catabolic process (GO:0006554) | 4.76299973 |
| 38 | lysine metabolic process (GO:0006553) | 4.76299973 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.74834660 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74600958 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.68608401 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.65430109 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.64642309 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.59387131 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.59309469 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.51378095 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.51128887 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.49118484 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.49118484 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49118484 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.47661250 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.47661250 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.39736606 |
| 54 | fatty acid homeostasis (GO:0055089) | 4.39437961 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.36695832 |
| 56 | actin filament-based movement (GO:0030048) | 4.32925675 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.29474089 |
| 58 | glycogen catabolic process (GO:0005980) | 4.29177156 |
| 59 | regulation of sequestering of triglyceride (GO:0010889) | 4.27998034 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.26912455 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.26912455 |
| 62 | phospholipid efflux (GO:0033700) | 4.25702095 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.22826004 |
| 64 | oxaloacetate metabolic process (GO:0006107) | 4.22778312 |
| 65 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.21372871 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.20219571 |
| 67 | fructose metabolic process (GO:0006000) | 4.19100951 |
| 68 | fibrinolysis (GO:0042730) | 4.16532434 |
| 69 | cellular glucuronidation (GO:0052695) | 4.14558578 |
| 70 | glucan catabolic process (GO:0009251) | 4.12793359 |
| 71 | glycine metabolic process (GO:0006544) | 4.09270492 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.06852479 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.05838051 |
| 74 | cholesterol efflux (GO:0033344) | 4.03723124 |
| 75 | carnitine shuttle (GO:0006853) | 4.03643390 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.97695388 |
| 77 | drug catabolic process (GO:0042737) | 3.95739334 |
| 78 | striated muscle contraction (GO:0006941) | 3.94807541 |
| 79 | myofibril assembly (GO:0030239) | 3.93811284 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 3.92761254 |
| 81 | aldehyde catabolic process (GO:0046185) | 3.92399968 |
| 82 | arginine metabolic process (GO:0006525) | 3.91798269 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.90851065 |
| 84 | cellular polysaccharide catabolic process (GO:0044247) | 3.89608904 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 3.89359535 |
| 86 | amine catabolic process (GO:0009310) | 3.89359535 |
| 87 | glutamate metabolic process (GO:0006536) | 3.89277983 |
| 88 | imidazole-containing compound metabolic process (GO:0052803) | 3.89030126 |
| 89 | ethanol oxidation (GO:0006069) | 3.88979579 |
| 90 | sarcomere organization (GO:0045214) | 3.88124372 |
| 91 | triglyceride catabolic process (GO:0019433) | 3.82654400 |
| 92 | low-density lipoprotein particle clearance (GO:0034383) | 3.82348440 |
| 93 | fatty acid transmembrane transport (GO:1902001) | 3.77296792 |
| 94 | response to muscle activity (GO:0014850) | 3.75293256 |
| 95 | ketone body metabolic process (GO:1902224) | 3.75100637 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.73375978 |
| 97 | regulation of relaxation of muscle (GO:1901077) | 3.72473204 |
| 98 | positive regulation of lipid catabolic process (GO:0050996) | 3.71220627 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.70474465 |
| 100 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.70017092 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.68983837 |
| 102 | cofactor catabolic process (GO:0051187) | 3.67243366 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.66924155 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.66924155 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.66879650 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.66739701 |
| 107 | gluconeogenesis (GO:0006094) | 3.64983583 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63312249 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63312249 |
| 110 | epoxygenase P450 pathway (GO:0019373) | 3.62418385 |
| 111 | complement activation (GO:0006956) | 3.60321497 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.60160530 |
| 113 | acylglycerol catabolic process (GO:0046464) | 3.60026987 |
| 114 | neutral lipid catabolic process (GO:0046461) | 3.60026987 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.59696030 |
| 116 | organic acid catabolic process (GO:0016054) | 3.58835221 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.58835221 |
| 118 | cholesterol homeostasis (GO:0042632) | 3.58636674 |
| 119 | cytolysis (GO:0019835) | 3.58357790 |
| 120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.57773059 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56990328 |
| 122 | sterol homeostasis (GO:0055092) | 3.53934213 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.53652410 |
| 124 | phospholipid homeostasis (GO:0055091) | 3.53162803 |
| 125 | response to nitrosative stress (GO:0051409) | 3.52665784 |
| 126 | polysaccharide catabolic process (GO:0000272) | 3.52287520 |
| 127 | regulation of bile acid biosynthetic process (GO:0070857) | 3.52236822 |
| 128 | regulation of plasminogen activation (GO:0010755) | 3.50929534 |
| 129 | protein activation cascade (GO:0072376) | 3.50779108 |
| 130 | blood coagulation, intrinsic pathway (GO:0007597) | 3.48497082 |
| 131 | exogenous drug catabolic process (GO:0042738) | 3.47231628 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46491648 |
| 133 | glucan biosynthetic process (GO:0009250) | 3.37304708 |
| 134 | glycogen biosynthetic process (GO:0005978) | 3.37304708 |
| 135 | fatty acid beta-oxidation (GO:0006635) | 3.37160759 |
| 136 | tricarboxylic acid cycle (GO:0006099) | 3.35335141 |
| 137 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.35000279 |
| 138 | hexose biosynthetic process (GO:0019319) | 3.34720920 |
| 139 | skeletal muscle fiber development (GO:0048741) | 3.32920426 |
| 140 | fatty acid catabolic process (GO:0009062) | 3.27953319 |
| 141 | response to mercury ion (GO:0046689) | 3.27509816 |
| 142 | daunorubicin metabolic process (GO:0044597) | 3.22400293 |
| 143 | polyketide metabolic process (GO:0030638) | 3.22400293 |
| 144 | doxorubicin metabolic process (GO:0044598) | 3.22400293 |
| 145 | ethanol metabolic process (GO:0006067) | 3.18995773 |
| 146 | * muscle contraction (GO:0006936) | 3.15296230 |
| 147 | actomyosin structure organization (GO:0031032) | 3.09569086 |
| 148 | carnitine transmembrane transport (GO:1902603) | 3.08731531 |
| 149 | monosaccharide biosynthetic process (GO:0046364) | 3.07563406 |
| 150 | carnitine transport (GO:0015879) | 3.07018447 |
| 151 | amino-acid betaine transport (GO:0015838) | 3.07018447 |
| 152 | cardiac myofibril assembly (GO:0055003) | 3.06143626 |
| 153 | fatty acid oxidation (GO:0019395) | 3.04507987 |
| 154 | cardiac muscle contraction (GO:0060048) | 3.01441729 |
| 155 | lipid oxidation (GO:0034440) | 2.99222634 |
| 156 | myotube cell development (GO:0014904) | 2.97546922 |
| 157 | monocarboxylic acid catabolic process (GO:0072329) | 2.95961133 |
| 158 | skeletal muscle adaptation (GO:0043501) | 2.95064764 |
| 159 | succinate metabolic process (GO:0006105) | 2.94271260 |
| 160 | tricarboxylic acid metabolic process (GO:0072350) | 2.93793791 |
| 161 | glycogen metabolic process (GO:0005977) | 2.89380651 |
| 162 | glucan metabolic process (GO:0044042) | 2.86522390 |
| 163 | cellular glucan metabolic process (GO:0006073) | 2.86522390 |
| 164 | omega-hydroxylase P450 pathway (GO:0097267) | 2.84764809 |
| 165 | response to inactivity (GO:0014854) | 2.83234465 |
| 166 | plasma membrane repair (GO:0001778) | 2.83029728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.98675425 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88384526 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.25872361 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.24027827 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.15276002 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85535232 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55911049 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01298247 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.54455739 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.77643498 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50296772 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15701216 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3405617 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.91051511 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88830626 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.84030320 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74043911 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71958436 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64092534 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57011055 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.48566444 |
| 22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43566192 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38800509 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37506983 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32015391 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31600660 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29516377 |
| 28 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.28766809 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27441068 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26019388 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22966781 |
| 32 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.19406704 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16932432 |
| 34 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16543168 |
| 35 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16165888 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13072883 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10208607 |
| 38 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.08378802 |
| 39 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06398854 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05684450 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04827760 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04392711 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02997717 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02453246 |
| 45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01313129 |
| 46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01191976 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01150007 |
| 48 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00959729 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98377803 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96842044 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96393962 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95383063 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93946325 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93394510 |
| 55 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92934714 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91154903 |
| 57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.90433496 |
| 58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89581659 |
| 59 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89442578 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88909030 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87198009 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87198009 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84203761 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83788308 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82214064 |
| 66 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82068566 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81949686 |
| 68 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80965007 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80136843 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79896034 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79322219 |
| 72 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79063196 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78799582 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77149376 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76430960 |
| 76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.76162470 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75061600 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74178090 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73500876 |
| 80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72373277 |
| 81 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71917689 |
| 82 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71917689 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67710335 |
| 84 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67056983 |
| 85 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66452718 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.66066330 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.65467558 |
| 88 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65449073 |
| 89 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.64233544 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63902107 |
| 91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.63758527 |
| 92 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63142214 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62680118 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.60986298 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.60112967 |
| 96 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60098347 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59995343 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59434764 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58151500 |
| 100 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.57723844 |
| 101 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57697291 |
| 102 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.55893393 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.55354341 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.54543833 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53964864 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53565536 |
| 107 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.52907524 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52755339 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52219785 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52027837 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51365833 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50825455 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.50436574 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49943106 |
| 115 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49659130 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49163144 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48860275 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47908345 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46905216 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46449342 |
| 121 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.45382629 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.44695193 |
| 123 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.44455825 |
| 124 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.44429804 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43385431 |
| 126 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42973078 |
| 127 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42268046 |
| 128 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42042660 |
| 129 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41262602 |
| 130 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.38745797 |
| 131 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38670713 |
| 132 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.38116566 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.37945520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.98192924 |
| 2 | MP0005360_urolithiasis | 7.08796007 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22034487 |
| 4 | MP0005365_abnormal_bile_salt | 5.92503458 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.86521307 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.31381627 |
| 7 | MP0003252_abnormal_bile_duct | 3.87168190 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.33299522 |
| 9 | MP0005083_abnormal_biliary_tract | 3.24628431 |
| 10 | MP0009840_abnormal_foam_cell | 3.21767412 |
| 11 | MP0005332_abnormal_amino_acid | 2.57231000 |
| 12 | MP0003195_calcinosis | 2.50499517 |
| 13 | MP0000759_abnormal_skeletal_muscle | 2.44848748 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.44838967 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.43737100 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.19290424 |
| 17 | MP0005369_muscle_phenotype | 2.08122799 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.07837025 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.06414896 |
| 20 | MP0000609_abnormal_liver_physiology | 2.02880406 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.97090767 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.93287721 |
| 23 | MP0005375_adipose_tissue_phenotype | 1.91246370 |
| 24 | MP0000750_abnormal_muscle_regeneration | 1.90339796 |
| 25 | MP0003868_abnormal_feces_composition | 1.87704053 |
| 26 | MP0005451_abnormal_body_composition | 1.85485346 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.82287747 |
| 28 | MP0004233_abnormal_muscle_weight | 1.80479377 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.78883020 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.77291704 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.76299933 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.74253136 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.73908666 |
| 34 | MP0009697_abnormal_copulation | 1.72003379 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.53865401 |
| 36 | MP0000003_abnormal_adipose_tissue | 1.47833522 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43906737 |
| 38 | MP0001764_abnormal_homeostasis | 1.40039342 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.35514959 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.33931566 |
| 41 | MP0000733_abnormal_muscle_development | 1.32614014 |
| 42 | MP0004510_myositis | 1.29003386 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.28342704 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.26316740 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 1.26316740 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.26043508 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.21392123 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.21187545 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.19933269 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.18266728 |
| 51 | MP0004484_altered_response_of | 1.17693526 |
| 52 | MP0003186_abnormal_redox_activity | 1.16264567 |
| 53 | MP0000598_abnormal_liver_morphology | 1.15274801 |
| 54 | MP0003011_delayed_dark_adaptation | 1.08588818 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.05612848 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.04480298 |
| 57 | MP0005408_hypopigmentation | 1.00959803 |
| 58 | MP0005647_abnormal_sex_gland | 1.00738622 |
| 59 | MP0004272_abnormal_basement_membrane | 0.98333665 |
| 60 | MP0004130_abnormal_muscle_cell | 0.97639735 |
| 61 | MP0002127_abnormal_cardiovascular_syste | 0.93707340 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.93506739 |
| 63 | MP0003959_abnormal_lean_body | 0.91014385 |
| 64 | MP0009764_decreased_sensitivity_to | 0.87719401 |
| 65 | MP0003879_abnormal_hair_cell | 0.86489906 |
| 66 | MP0000604_amyloidosis | 0.85932741 |
| 67 | MP0009763_increased_sensitivity_to | 0.85447665 |
| 68 | MP0003828_pulmonary_edema | 0.84682832 |
| 69 | MP0002971_abnormal_brown_adipose | 0.84602068 |
| 70 | MP0005670_abnormal_white_adipose | 0.83611584 |
| 71 | MP0008438_abnormal_cutaneous_collagen | 0.81660869 |
| 72 | MP0003718_maternal_effect | 0.80844909 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.80818687 |
| 74 | MP0002269_muscular_atrophy | 0.80305223 |
| 75 | MP0000749_muscle_degeneration | 0.79342288 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.78899800 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.78796135 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.78678207 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.78363203 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.76992465 |
| 81 | MP0009053_abnormal_anal_canal | 0.76325899 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.75701266 |
| 83 | MP0005165_increased_susceptibility_to | 0.73503656 |
| 84 | MP0005452_abnormal_adipose_tissue | 0.71140524 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70635330 |
| 86 | MP0005395_other_phenotype | 0.70204497 |
| 87 | MP0002254_reproductive_system_inflammat | 0.68858697 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.68477712 |
| 89 | MP0005266_abnormal_metabolism | 0.67066135 |
| 90 | MP0005334_abnormal_fat_pad | 0.66201284 |
| 91 | MP0008469_abnormal_protein_level | 0.66183601 |
| 92 | MP0000343_altered_response_to | 0.64398528 |
| 93 | MP0003075_altered_response_to | 0.62857223 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.61918564 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.61068918 |
| 96 | MP0001756_abnormal_urination | 0.59720222 |
| 97 | MP0002822_catalepsy | 0.58610328 |
| 98 | MP0003329_amyloid_beta_deposits | 0.56218650 |
| 99 | MP0005330_cardiomyopathy | 0.55818006 |
| 100 | MP0000747_muscle_weakness | 0.55808292 |
| 101 | MP0004087_abnormal_muscle_fiber | 0.55018016 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.54587979 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.54175878 |
| 104 | MP0001661_extended_life_span | 0.53733304 |
| 105 | MP0002928_abnormal_bile_duct | 0.53180001 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.52803929 |
| 107 | MP0003646_muscle_fatigue | 0.51971695 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.51383742 |
| 109 | MP0005275_abnormal_skin_tensile | 0.51113660 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.50289908 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.47477100 |
| 112 | MP0002168_other_aberrant_phenotype | 0.46948018 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.46927030 |
| 114 | MP0005023_abnormal_wound_healing | 0.46887594 |
| 115 | MP0003279_aneurysm | 0.46839295 |
| 116 | MP0005448_abnormal_energy_balance | 0.46431259 |
| 117 | MP0004085_abnormal_heartbeat | 0.46026891 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.45809435 |
| 119 | MP0005535_abnormal_body_temperature | 0.45161628 |
| 120 | MP0009672_abnormal_birth_weight | 0.44810526 |
| 121 | MP0000579_abnormal_nail_morphology | 0.44505780 |
| 122 | MP0001542_abnormal_bone_strength | 0.43291253 |
| 123 | MP0002060_abnormal_skin_morphology | 0.43123263 |
| 124 | MP0001243_abnormal_dermal_layer | 0.43057216 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.42276871 |
| 126 | MP0000751_myopathy | 0.41295340 |
| 127 | MP0009115_abnormal_fat_cell | 0.40886376 |
| 128 | MP0004883_abnormal_blood_vessel | 0.39155975 |
| 129 | MP0004145_abnormal_muscle_electrophysio | 0.38466605 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.37387469 |
| 131 | MP0002970_abnormal_white_adipose | 0.35630885 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.35330292 |
| 133 | MP0001915_intracranial_hemorrhage | 0.34903144 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.34588199 |
| 135 | MP0003953_abnormal_hormone_level | 0.33216825 |
| 136 | MP0005166_decreased_susceptibility_to | 0.33201722 |
| 137 | MP0000249_abnormal_blood_vessel | 0.32031020 |
| 138 | MP0002128_abnormal_blood_circulation | 0.31202036 |
| 139 | MP0003699_abnormal_female_reproductive | 0.30928023 |
| 140 | MP0006138_congestive_heart_failure | 0.30927745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 8.27881462 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.59562883 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.95407499 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.83168196 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.74267930 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.12746164 |
| 7 | Xanthomatosis (HP:0000991) | 5.96814707 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.92883578 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.82920740 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 5.37855046 |
| 11 | Complement deficiency (HP:0004431) | 5.24954630 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.97852714 |
| 13 | Distal arthrogryposis (HP:0005684) | 4.70387982 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.66797119 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.55846513 |
| 16 | Hyperammonemia (HP:0001987) | 4.35591735 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 4.33985894 |
| 18 | Myopathic facies (HP:0002058) | 4.33653829 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.28627386 |
| 20 | Round ear (HP:0100830) | 4.23941883 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16974460 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15552829 |
| 23 | Epidermoid cyst (HP:0200040) | 4.11839621 |
| 24 | Joint hemorrhage (HP:0005261) | 4.11757095 |
| 25 | Calf muscle hypertrophy (HP:0008981) | 4.09757602 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 4.09377730 |
| 27 | Ketosis (HP:0001946) | 4.08260666 |
| 28 | Hyperglycinemia (HP:0002154) | 4.07142187 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.06129059 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.91459335 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 3.90699185 |
| 32 | Muscle fiber splitting (HP:0003555) | 3.90655065 |
| 33 | Neck muscle weakness (HP:0000467) | 3.88345603 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85856906 |
| 35 | Abnormality of methionine metabolism (HP:0010901) | 3.85410666 |
| 36 | Fat malabsorption (HP:0002630) | 3.82359781 |
| 37 | Abnormality of complement system (HP:0005339) | 3.81652230 |
| 38 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.80982220 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.79383297 |
| 40 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.73656975 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 3.72926282 |
| 42 | Abnormality of the calf musculature (HP:0001430) | 3.65830043 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 3.65542856 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.61475335 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.60732275 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.55013714 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 3.55013714 |
| 48 | Hyperglycinuria (HP:0003108) | 3.54457621 |
| 49 | Increased connective tissue (HP:0009025) | 3.49260148 |
| 50 | Difficulty running (HP:0009046) | 3.37168541 |
| 51 | Muscle stiffness (HP:0003552) | 3.34350208 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31492575 |
| 53 | Hypercholesterolemia (HP:0003124) | 3.29784378 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29243999 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24589656 |
| 56 | Rimmed vacuoles (HP:0003805) | 3.23766251 |
| 57 | Conjugated hyperbilirubinemia (HP:0002908) | 3.10353660 |
| 58 | Hyperbilirubinemia (HP:0002904) | 3.02714117 |
| 59 | Sudden death (HP:0001699) | 3.01179599 |
| 60 | Subaortic stenosis (HP:0001682) | 3.00561708 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.00561708 |
| 62 | Hepatocellular carcinoma (HP:0001402) | 3.00232698 |
| 63 | Ketoacidosis (HP:0001993) | 2.95891476 |
| 64 | Cholecystitis (HP:0001082) | 2.92180955 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.92180955 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.88254896 |
| 67 | Steatorrhea (HP:0002570) | 2.88227779 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86334654 |
| 69 | Calcaneovalgus deformity (HP:0001848) | 2.85662485 |
| 70 | Myocardial infarction (HP:0001658) | 2.82368504 |
| 71 | Skin nodule (HP:0200036) | 2.74225008 |
| 72 | Bundle branch block (HP:0011710) | 2.73522756 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.72667789 |
| 74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.72586739 |
| 75 | Cholelithiasis (HP:0001081) | 2.72214525 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.71027826 |
| 77 | Absent phalangeal crease (HP:0006109) | 2.69157459 |
| 78 | Gout (HP:0001997) | 2.69053195 |
| 79 | Frequent falls (HP:0002359) | 2.67919708 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.64879982 |
| 81 | Spontaneous abortion (HP:0005268) | 2.63849291 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.60926824 |
| 83 | Metabolic acidosis (HP:0001942) | 2.59563420 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.54721119 |
| 85 | Ventricular tachycardia (HP:0004756) | 2.53430916 |
| 86 | Deformed tarsal bones (HP:0008119) | 2.51537068 |
| 87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49669356 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.49669356 |
| 89 | Dilated cardiomyopathy (HP:0001644) | 2.46633901 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.45606675 |
| 91 | Lethargy (HP:0001254) | 2.41369313 |
| 92 | Malignant hyperthermia (HP:0002047) | 2.41368370 |
| 93 | Gowers sign (HP:0003391) | 2.41033036 |
| 94 | Areflexia of lower limbs (HP:0002522) | 2.38813907 |
| 95 | Neonatal onset (HP:0003623) | 2.37936480 |
| 96 | Bulbar palsy (HP:0001283) | 2.37363684 |
| 97 | EMG: neuropathic changes (HP:0003445) | 2.34183494 |
| 98 | Myotonia (HP:0002486) | 2.29866420 |
| 99 | Spinal rigidity (HP:0003306) | 2.28526379 |
| 100 | Enlarged kidneys (HP:0000105) | 2.27716550 |
| 101 | Vascular calcification (HP:0004934) | 2.26773967 |
| 102 | Mitral stenosis (HP:0001718) | 2.26233351 |
| 103 | Late onset (HP:0003584) | 2.26130439 |
| 104 | Generalized muscle weakness (HP:0003324) | 2.25941184 |
| 105 | Cerebral edema (HP:0002181) | 2.24937268 |
| 106 | Slender build (HP:0001533) | 2.22943955 |
| 107 | Esophageal varix (HP:0002040) | 2.22461158 |
| 108 | Lipoatrophy (HP:0100578) | 2.21805729 |
| 109 | Malnutrition (HP:0004395) | 2.21218316 |
| 110 | Hypoglycemic seizures (HP:0002173) | 2.17267621 |
| 111 | Spastic diplegia (HP:0001264) | 2.14339723 |
| 112 | Scapular winging (HP:0003691) | 2.14259688 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.13483269 |
| 114 | Glomerulonephritis (HP:0000099) | 2.11138034 |
| 115 | Abnormal finger flexion creases (HP:0006143) | 2.10920485 |
| 116 | Acanthocytosis (HP:0001927) | 2.10754081 |
| 117 | Abnormal atrioventricular conduction (HP:0005150) | 2.09966583 |
| 118 | Abnormality of the gallbladder (HP:0005264) | 2.08972424 |
| 119 | Hyperglycemia (HP:0003074) | 2.08291263 |
| 120 | Myoglobinuria (HP:0002913) | 2.07375708 |
| 121 | Oligomenorrhea (HP:0000876) | 2.07247856 |
| 122 | Limb-girdle muscle atrophy (HP:0003797) | 2.06367750 |
| 123 | Heart block (HP:0012722) | 2.05195865 |
| 124 | Irritability (HP:0000737) | 2.02429447 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.01498714 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 1.97716876 |
| 127 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96790877 |
| 128 | Generalized aminoaciduria (HP:0002909) | 1.93799624 |
| 129 | Amyloidosis (HP:0011034) | 1.92875758 |
| 130 | Brushfield spots (HP:0001088) | 1.92759773 |
| 131 | Abnormality of placental membranes (HP:0011409) | 1.92011873 |
| 132 | Amniotic constriction ring (HP:0009775) | 1.92011873 |
| 133 | Back pain (HP:0003418) | 1.89583846 |
| 134 | Increased purine levels (HP:0004368) | 1.88510746 |
| 135 | Hyperuricemia (HP:0002149) | 1.88510746 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.88214917 |
| 137 | Pancreatitis (HP:0001733) | 1.87579123 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.87521207 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.87521207 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86544195 |
| 141 | Progressive muscle weakness (HP:0003323) | 1.86486679 |
| 142 | Increased muscle lipid content (HP:0009058) | 1.85819135 |
| 143 | Type 1 muscle fiber predominance (HP:0003803) | 1.85064909 |
| 144 | Vomiting (HP:0002013) | 1.84576205 |
| 145 | Popliteal pterygium (HP:0009756) | 1.83449138 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.83117021 |
| 147 | Abnormality of the Achilles tendon (HP:0005109) | 1.82426716 |
| 148 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.81273201 |
| 149 | Rhabdomyolysis (HP:0003201) | 1.80153206 |
| 150 | Fetal akinesia sequence (HP:0001989) | 1.79659808 |
| 151 | Menorrhagia (HP:0000132) | 1.78590938 |
| 152 | Muscle fiber inclusion bodies (HP:0100299) | 1.78478363 |
| 153 | Increased serum pyruvate (HP:0003542) | 1.76926265 |
| 154 | Proximal tubulopathy (HP:0000114) | 1.76520582 |
| 155 | Difficulty climbing stairs (HP:0003551) | 1.75260690 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.74922955 |
| 157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73023143 |
| 158 | Atrioventricular block (HP:0001678) | 1.73000344 |
| 159 | Thrombophlebitis (HP:0004418) | 1.72956601 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71573840 |
| 161 | Hip contracture (HP:0003273) | 1.70831431 |
| 162 | Achilles tendon contracture (HP:0001771) | 1.69795202 |
| 163 | Weak cry (HP:0001612) | 1.69657362 |
| 164 | Abnormality of the calcaneus (HP:0008364) | 1.69384029 |
| 165 | Ventricular arrhythmia (HP:0004308) | 1.69334747 |
| 166 | Lower limb amyotrophy (HP:0007210) | 1.66700567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.43729619 |
| 2 | ERN1 | 3.48729617 |
| 3 | FGFR4 | 3.45864865 |
| 4 | SIK1 | 3.45716457 |
| 5 | LATS1 | 3.27263383 |
| 6 | TRIB3 | 3.12759069 |
| 7 | TAOK3 | 3.06841455 |
| 8 | PKN2 | 2.75939866 |
| 9 | ERBB4 | 2.69617536 |
| 10 | STK38L | 2.60717333 |
| 11 | OBSCN | 2.54203572 |
| 12 | PIK3CG | 2.33162415 |
| 13 | LATS2 | 2.13859570 |
| 14 | MAP2K4 | 2.02945970 |
| 15 | NEK9 | 2.01105597 |
| 16 | MOS | 1.95097616 |
| 17 | FLT3 | 1.80898390 |
| 18 | INSRR | 1.73925290 |
| 19 | TESK1 | 1.68142815 |
| 20 | LIMK1 | 1.54007998 |
| 21 | MST1R | 1.53719794 |
| 22 | MAPK11 | 1.49017782 |
| 23 | EPHA3 | 1.35590122 |
| 24 | FRK | 1.34982363 |
| 25 | ABL2 | 1.34749056 |
| 26 | PTK6 | 1.32727236 |
| 27 | MAP2K3 | 1.31854659 |
| 28 | TTN | 1.18748731 |
| 29 | MAPKAPK3 | 1.18252483 |
| 30 | MAP3K7 | 1.15167103 |
| 31 | PRPF4B | 1.13659453 |
| 32 | PDK2 | 1.11929808 |
| 33 | KSR2 | 1.07160112 |
| 34 | PRKAA2 | 1.05145007 |
| 35 | PTK2 | 1.01457429 |
| 36 | MAP3K3 | 1.00851570 |
| 37 | MAP2K1 | 1.00284280 |
| 38 | STK3 | 0.94567151 |
| 39 | TAOK2 | 0.93139219 |
| 40 | PINK1 | 0.90041990 |
| 41 | NEK1 | 0.89019199 |
| 42 | IRAK3 | 0.89001379 |
| 43 | EEF2K | 0.86561659 |
| 44 | MET | 0.86473945 |
| 45 | DMPK | 0.85691259 |
| 46 | MAP3K10 | 0.85568178 |
| 47 | STK24 | 0.85525887 |
| 48 | RET | 0.84982341 |
| 49 | TYK2 | 0.83819540 |
| 50 | MAP3K6 | 0.82845172 |
| 51 | PDGFRA | 0.80259621 |
| 52 | ERBB2 | 0.79169928 |
| 53 | ICK | 0.77991907 |
| 54 | MAP3K11 | 0.73013760 |
| 55 | DAPK2 | 0.72971836 |
| 56 | PRKAA1 | 0.72391600 |
| 57 | SCYL2 | 0.72321918 |
| 58 | JAK2 | 0.72264210 |
| 59 | CAMK2G | 0.71274452 |
| 60 | MAPK12 | 0.71175840 |
| 61 | PIK3CA | 0.70871421 |
| 62 | PIM2 | 0.70224451 |
| 63 | CAMK2D | 0.70055967 |
| 64 | TGFBR2 | 0.69721691 |
| 65 | PHKG2 | 0.68497746 |
| 66 | PHKG1 | 0.68497746 |
| 67 | KDR | 0.67896544 |
| 68 | PDK4 | 0.67190821 |
| 69 | PDK3 | 0.67190821 |
| 70 | AKT2 | 0.67063229 |
| 71 | BMPR2 | 0.65164574 |
| 72 | PRKG2 | 0.64018105 |
| 73 | EPHB1 | 0.64007489 |
| 74 | CDK6 | 0.63208267 |
| 75 | MAP3K5 | 0.62337003 |
| 76 | MYLK | 0.62200119 |
| 77 | FGFR2 | 0.60564729 |
| 78 | TBK1 | 0.58159595 |
| 79 | PRKCZ | 0.57402589 |
| 80 | RIPK1 | 0.57089703 |
| 81 | MAPK7 | 0.55818763 |
| 82 | MAP2K6 | 0.55612572 |
| 83 | TIE1 | 0.54633496 |
| 84 | FER | 0.54390668 |
| 85 | MUSK | 0.54224161 |
| 86 | PRKG1 | 0.53517754 |
| 87 | MTOR | 0.53391547 |
| 88 | PAK3 | 0.51900016 |
| 89 | DDR2 | 0.51841692 |
| 90 | MAPK4 | 0.51197614 |
| 91 | MAP3K13 | 0.51065640 |
| 92 | JAK1 | 0.50518676 |
| 93 | CAMK1 | 0.47468590 |
| 94 | LRRK2 | 0.45289993 |
| 95 | NTRK1 | 0.44819235 |
| 96 | NUAK1 | 0.44158604 |
| 97 | MAP3K12 | 0.43116685 |
| 98 | PRKACG | 0.42445452 |
| 99 | PDK1 | 0.42438512 |
| 100 | PRKD1 | 0.42347655 |
| 101 | GSK3A | 0.42334610 |
| 102 | ARAF | 0.40538783 |
| 103 | CDC42BPA | 0.40236895 |
| 104 | TESK2 | 0.39093939 |
| 105 | DYRK1B | 0.37931933 |
| 106 | TRPM7 | 0.37855454 |
| 107 | CAMK2B | 0.37607313 |
| 108 | EPHA2 | 0.37370563 |
| 109 | PRKD2 | 0.36376032 |
| 110 | DAPK3 | 0.35874151 |
| 111 | ZAP70 | 0.35364157 |
| 112 | FGFR3 | 0.34667330 |
| 113 | EPHB2 | 0.33672446 |
| 114 | MAP3K2 | 0.33585949 |
| 115 | ROCK1 | 0.33377062 |
| 116 | SGK3 | 0.32860159 |
| 117 | NME1 | 0.32674889 |
| 118 | IGF1R | 0.30935242 |
| 119 | PRKACA | 0.30602135 |
| 120 | ILK | 0.30485965 |
| 121 | CSNK1G1 | 0.30479649 |
| 122 | CAMK4 | 0.29679303 |
| 123 | PAK2 | 0.28503053 |
| 124 | LMTK2 | 0.28429996 |
| 125 | MAPK15 | 0.26867073 |
| 126 | TAOK1 | 0.26477182 |
| 127 | CAMK1D | 0.25983845 |
| 128 | MAP3K1 | 0.25761850 |
| 129 | PDPK1 | 0.25596650 |
| 130 | STK10 | 0.24795168 |
| 131 | STK38 | 0.24323459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45011931 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.45993063 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32465567 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28662985 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99417827 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78370200 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68916686 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68243635 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65954347 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59562004 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50054242 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46644344 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15705557 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07838295 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06335366 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06214605 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.04883278 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93666607 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87494818 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86756271 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83071267 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78406580 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77262218 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71239836 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69159645 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68728194 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67192234 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66881936 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59661896 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59106456 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59089063 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55711864 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54001118 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53322638 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52658961 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49585222 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.49575177 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42251372 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39890478 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33178967 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32140730 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29317125 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26885175 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24116465 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22342393 |
| 46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20430907 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16474630 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08325533 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.05786631 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02351161 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02042187 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95506111 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95359122 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90250749 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88311206 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87008617 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86684761 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83198484 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81602854 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81064977 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.78216233 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72913458 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72587093 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69823405 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69167414 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66225089 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65516289 |
| 68 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64279784 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61746625 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50185643 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49102685 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43310783 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.42495346 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.39997579 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35215315 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.35091455 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32448200 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31975800 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.30971428 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30106485 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.29836930 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28527003 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28422280 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25200869 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24820144 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.24601987 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23408811 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22737604 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22590610 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.19891018 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16916566 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16090510 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12959179 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10391702 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00939358 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00522735 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00461293 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00135059 |
| 99 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1904179 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1830451 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.1744523 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1739797 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.1649385 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1546659 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1507052 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1352115 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1138250 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.1013204 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0973336 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | -0.0773515 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0677717 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0647665 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | -0.0506828 |

